-+ 0.00%
-+ 0.00%
-+ 0.00%

NEXALIN ANNOUNCES PIVOTAL HALO™ CLARITY TRIAL TO SUPPORT PLANNED DE NOVO FDA SUBMISSION TARGETING MULTI-BILLION-DOLLAR INSOMNIA MARKET

Reuters·02/24/2026 13:07:00

Please log in to view news